Blencowe Resources: Aspiring to become one of the largest graphite producers in the world. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBraveheart Inv Regulatory News (BRH)

Share Price Information for Braveheart Inv (BRH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 7.25
Bid: 7.00
Ask: 7.50
Change: 0.50 (7.41%)
Spread: 0.50 (7.143%)
Open: 6.75
High: 7.25
Low: 6.75
Prev. Close: 6.75
BRH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Posting of annual report and notice of AGM

5 Jul 2023 07:00

RNS Number : 9488E
Braveheart Investment Group plc
05 July 2023
 

5 July 2023

Braveheart Investment Group plc

("Braveheart", the "Company" or the "Group")

 

Posting of annual report and accounts, notice of AGM and

proposed amendment to investment strategy

 

Braveheart Investment Group (AIM: BRH), announces that the Company's annual report and accounts for the year ended 31 March 2023, which incorporates notice of the Company's 2023 Annual General Meeting ("AGM") will be posted to shareholders today and will be available to download from the Company's website at www.braveheartgroup.co.uk.

 

The AGM will be held on 28 July 2023 at 10.30 am at the office of China Ventures Ltd, Unit 2, Common Farm, Common Lane, Mappleborough Green, Warwickshire, B80 7DP.

 

Proposed amendments to the Group's investment strategy

 

The AGM notice contains a resolution (the "Investment Strategy Resolution") to permit the Directors to replace the Company's investment strategy (the "Investment Strategy") as set out in part 1 of the Company's admission document dated 27 March 2007, which determines the permitted business and strategy of the Company.

 

The proposed new Investment Strategy is set out below:

 

The Group's strategy is to invest in early and later-stage businesses, primarily in the technology sector, but it will also consider opportunities in other sectors that are knowledge intensive, such as healthcare and professional services.

 

The Group will target investments in both unlisted and listed companies, where there is potential for significant growth. Investments are expected to be mainly in the form of equity and equity-related instruments, including convertible debt instruments in certain circumstances.

 

The Group may acquire investments directly or by way of holdings in intermediate holding or subsidiary entities. The Group might also invest in limited liability partnerships and other forms of legal entity. Where possible, the Group will seek investor protection rights, as determined by the Board.

 

The Group may offer its Ordinary Shares in exchange for shares in investee businesses in addition to a cash investment in such businesses.

 

For unlisted company investments, the Group targets companies at different stages of development, ranging from those which are just starting to trade to those which are expecting to achieve an IPO in the short term, thus providing portfolio diversification. These investments will typically involve active investment management.

 

The Group, where appropriate and deemed by the Board to be in the Group's best interests, may seek a position on the boards of unlisted investee companies. The Group where appropriate, will assist the board and management of investee companies, including helping to scale management teams, informing strategy and assisting with future financing.

 

For listed company investments, the Group targets investments where the Board considers the shares are undervalued but there are opportunities for significant growth. These investments will typically involve passive investment management, although the Board may take a more active approach if it considers there is a need to effect change.

 

Braveheart may occasionally invest in companies that are in rescue or distress situations where a value-creating opportunity has been identified. The Group does not have any maximum exposure limits but will generally take a minority stake in a business and look for investments where there is a good prospect of an exit in a two-to-five-year time period.

 

As risk reduces, the Group may increase its investment in subsequent rounds of funding and, as those businesses grow, may find itself holding a controlling interest in some trading companies. However, in such instances the Board will ensure that there is sufficient separation between the Group and the investee company so that the investee company does not become a trading company of the Group.

 

Full details of the proposed amendments to the Investment Strategy are set out in the explanatory notes to the notice of AGM. Should the Investment Strategy Resolution not be passed at the AGM, the Company will not be able to make the proposed amendments to the Investment Strategy. A further announcement will be made on conclusion of the AGM.

 

For further information:

Braveheart Investment Group plc

Tel: 01738 587555

Trevor Brown, Chief Executive Officer

Viv Hallam, Executive Director

Allenby Capital Limited (Nominated Adviser and Joint Broker)

Tel: 020 3328 5656

James Reeve / George Payne

Peterhouse Capital Limited (Joint Broker)

Tel: 020 7469 0936

Duncan Vasey / Lucy Williams

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NOANKQBBNBKDCOK
Date   Source Headline
16th Jul 20187:00 amRNSUpdate on fund management business
12th Jul 20187:00 amRNSProposed funding round by Paraytec Limited
10th Jul 201810:44 amRNSHolding(s) in Company
25th Jun 20187:00 amRNSFurther re. Notice of Annual General Meeting
21st Jun 20185:16 pmRNSConfirmation of Posting
20th Jun 201810:30 amRNSAppointment of Joint Broker
18th Jun 20187:02 amRNSNotice of General Meeting
18th Jun 20187:00 amRNSFinal Results
26th Apr 20187:00 amRNSTrading Update
9th Apr 20185:11 pmRNSThird party investment into Gyrometric Systems Ltd
16th Jan 20184:24 pmRNSChange of Registered Office
19th Oct 20177:00 amRNSHalf-year Report
13th Sep 20177:00 amRNSUpdate re. Portfolio investment
1st Sep 20177:00 amRNSRetirement of Director and Total Voting Rights
8th Aug 20177:00 amRNSIssue of Equity
20th Jul 201711:19 amRNSResult of AGM
20th Jul 20177:00 amRNSAGM Statement
21st Jun 20177:00 amRNSFinal Results for the year ended 31 March 2017
7th Jun 20174:08 pmRNSDirectorate Change
20th Apr 20177:00 amRNSTrading Update
9th Jan 20177:00 amRNSStrategic Investment and Trading Update
12th Oct 20167:00 amRNSHalf-year Report
16th Sep 201611:18 amRNSDisposal of interest in Investee Company
2nd Aug 201612:08 pmRNSConditional disposal of interest-Investee Company
29th Jul 201611:13 amRNSStmnt re Share Price Movement
26th Jul 20169:32 amRNSHolding(s) in Company
19th Jul 201611:46 amRNSResult of AGM
19th Jul 20167:00 amRNSAGM Statement
13th Jul 20163:26 pmRNSDirectors' Dealings
8th Jul 20163:07 pmRNSInvestment in Kirkstall Limited
4th Jul 20167:00 amRNSInvestment in Paraytec Limited
23rd Jun 20168:45 amRNSAnnual Results
3rd Mar 20167:00 amRNSChange of Nomad & Broker and Directorate Changes
15th Jan 20169:36 amRNSDirectors' Dealings
8th Jan 201612:36 pmRNSDisposal of interest in WhiteRock Capital Partners
15th Dec 20152:33 pmRNSCompletion of sale of interest in Biopta
27th Nov 20157:00 amRNSDisposal of interest in Investee Company
2nd Nov 20152:35 pmRNSHalf Yearly Report & Disposal
24th Sep 201512:15 pmRNSResult of AGM and Directorate Change
3rd Sep 20157:00 amRNSDirector/PDMR Shareholding
2nd Sep 201512:30 pmRNSPosting of Results and Notice of AGM
24th Aug 20157:00 amRNSPreliminary Results and Board Changes
26th Jun 20152:20 pmRNSChange of address and registered office
6th May 20157:01 amRNSCompletion of restructuring and Directorate change
30th Apr 201511:21 amRNSBraveheart enters into partnership with Seedrs
30th Apr 20157:00 amRNSTermination of partnership
20th Apr 20157:00 amRNSDirectorate Change
23rd Dec 20147:00 amRNSRealisation of Investment
15th Dec 20147:00 amRNSHalf Yearly Report
4th Dec 20147:00 amRNSLondon Co-investment Fund partnership

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.